Neal M. Davies - Publications

Affiliations: 
Washington State University, Pullman, WA, United States 
Area:
Pharmacology, Toxicology, Pharmaceutical Chemistry

114 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 O'Croinin C, Le TS, Doschak M, Löbenberg R, Davies NM. A validated method for detection of cannflavins in hemp extracts. Journal of Pharmaceutical and Biomedical Analysis. 235: 115631. PMID 37586306 DOI: 10.1016/j.jpba.2023.115631  0.31
2022 Al Nebaihi HM, Le TS, Davies NM, Brocks DR. Analysis of cycloheximide in rat specimens using liquid chromatography with tandem massspectrometry detection. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 1190: 123112. PMID 35032893 DOI: 10.1016/j.jchromb.2022.123112  0.356
2020 Amaral Silva D, Davies NM, Doschak MR, Al-Gousous J, Bou-Chacra N, Löbenberg R. Mechanistic understanding of underperforming enteric coated products: Opportunities to add clinical relevance to the dissolution test. Journal of Controlled Release : Official Journal of the Controlled Release Society. 325: 323-334. PMID 32649973 DOI: 10.1016/J.Jconrel.2020.06.031  0.306
2020 Silva DA, Al-Gousous J, Davies NM, Chacra NB, Webster GK, Lipka E, Amidon GL, Löbenberg R. Biphasic Dissolution as an Exploratory Method During Early Drug Product Development. Pharmaceutics. 12. PMID 32370237 DOI: 10.3390/Pharmaceutics12050420  0.324
2018 Brocks DR, Davies NM. Lymphatic Drug Absorption via the Enterocytes: Pharmacokinetic Simulation, Modeling, and Considerations for Optimal Drug Development. Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society For Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques. 21: 254s-270s. PMID 30348249 DOI: 10.18433/Jpps30217  0.305
2018 Silva DA, Löbenberg R, Davies N. Are Excipients Inert? Phenytoin Pharmaceutical Investigations with New Incompatibility Insights. Journal of Pharmacy and Pharmaceutical Sciences. 21: 29745. PMID 29702046 DOI: 10.18433/Jpps29745  0.303
2017 Novaes JT, Lillico R, Sayre CL, Nagabushnam K, Majeed M, Chen Y, Ho EA, Oliveira ALP, Martinez SE, Alrushaid S, Davies NM, Lakowski TM. Disposition, Metabolism and Histone Deacetylase and Acetyltransferase Inhibition Activity of Tetrahydrocurcumin and Other Curcuminoids. Pharmaceutics. 9. PMID 29023392 DOI: 10.3390/Pharmaceutics9040045  0.369
2017 Alrushaid S, Sayre CL, Yáñez JA, Forrest ML, Senadheera SN, Burczynski FJ, Löbenberg R, Davies NM. Pharmacokinetic and Toxicodynamic Characterization of a Novel Doxorubicin Derivative. Pharmaceutics. 9. PMID 28902176 DOI: 10.3390/Pharmaceutics9030035  0.386
2017 Martinez SE, Lillico R, Lakowski TM, Martinez SA, Davies NM. Pharmacokinetic Analysis of an Oral Multicomponent Joint Dietary Supplement (Phycox(®)) in Dogs. Pharmaceutics. 9. PMID 28820428 DOI: 10.3390/Pharmaceutics9030030  0.419
2017 Alrushaid S, Davies NM, Martinez SE, Sayre CL. Stereospecific pharmacokinetic characterization of liquiritigenin in the rat. Research in Pharmaceutical Sciences. 12: 176-186. PMID 28626475 DOI: 10.4103/1735-5362.207197  0.415
2017 Alrushaid S, Zhao Y, Sayre CL, Maayah ZH, Laird Forrest M, Senadheera SN, Chaboyer K, Anderson HD, El-Kadi AOS, Davies NM. Mechanistically elucidating the in vitro safety and efficacy of a novel doxorubicin derivative. Drug Delivery and Translational Research. PMID 28462502 DOI: 10.1007/S13346-017-0379-2  0.343
2017 Malhi S, Stesco N, Alrushaid S, Lakowski TM, Davies NM, Gu X. Simultaneous quantification of reparixin and paclitaxel in plasma and urine using ultra performance liquid chromatography-tandem mass spectroscopy (UHPLC-MS/MS): Application to a preclinical pharmacokinetic study in rats. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 1046: 165-171. PMID 28187377 DOI: 10.1016/J.Jchromb.2016.12.015  0.404
2016 Alrushaid S, Davies NM, Martinez SE, Sayre CL. Pharmacological characterization of liquiritigenin, a chiral flavonoid in licorice. Research in Pharmaceutical Sciences. 11: 355-365. PMID 27920817 DOI: 10.4103/1735-5362.192484  0.318
2016 Lillico R, Sayre CL, Sitar DS, Davies NM, Baron CM, Lakowski TM. Quantification of cefazolin in serum and adipose tissue by ultra high performance liquid chromatography-Tandem mass spectrometry (UHPLC-MS/MS): application to a pilot study of obese women undergoing cesarean delivery. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 1031: 94-98. PMID 27469905 DOI: 10.1016/J.Jchromb.2016.07.032  0.352
2015 Takemoto JK, Remsberg CM, Davies NM. Pharmacologic Activities¬ of 3'-Hydroxypterostilbene: Cytotoxic, Anti-Oxidant, Anti-Adipogenic, Anti-Inflammatory, Histone Deacetylase and Sirtuin 1 Inhibitory Activity. Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society For Pharmaceutical Sciences, SociéTé Canadienne Des Sciences Pharmaceutiques. 18: 713-27. PMID 26626255 DOI: 10.18433/J33W4C  0.762
2015 Oliveira AL, Martinez SE, Nagabushnam K, Majeed M, Alrushaid S, Sayre CL, Davies NM. Calebin A: Analytical Development for Pharmacokinetics Study, Elucidation of Pharmacological Activities and Content Analysis of Natural Health Products. Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society For Pharmaceutical Sciences, SociéTé Canadienne Des Sciences Pharmaceutiques. 18: 494-514. PMID 26626247 DOI: 10.18433/J32310  0.359
2015 Sayre CL, Alrushaid S, Martinez SE, Anderson HD, Davies NM. Pre-Clinical Pharmacokinetic and Pharmacodynamic Characterization of Selected Chiral Flavonoids: Pinocembrin and Pinostrobin. Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society For Pharmaceutical Sciences, SociéTé Canadienne Des Sciences Pharmaceutiques. 18: 368-95. PMID 26626242 DOI: 10.18433/J3Bk5T  0.306
2015 Emami J, Rezazadeh M, Hasanzadeh F, Sadeghi H, Mostafavi A, Minaiyan M, Rostami M, Davies N. Development and in vitro/in vivo evaluation of a novel targeted polymeric micelle for delivery of paclitaxel. International Journal of Biological Macromolecules. 80: 29-40. PMID 26093319 DOI: 10.1016/J.Ijbiomac.2015.05.062  0.302
2015 Martinez SE, Davies NM. Enantiospecific pharmacokinetics of isoxanthohumol and its metabolite 8-prenylnaringenin in the rat. Molecular Nutrition & Food Research. PMID 26079861 DOI: 10.1002/Mnfr.201500118  0.392
2015 Remsberg CM, Martinez SE, Akinwumi BC, Anderson HD, Takemoto JK, Sayre CL, Davies NM. Preclinical Pharmacokinetics and Pharmacodynamics and Content Analysis of Gnetol in Foodstuffs. Phytotherapy Research : Ptr. PMID 25939395 DOI: 10.1002/Ptr.5363  0.8
2015 Barry SL, Martinez SA, Davies NM, Remsberg CM, Sayre CL, Bachelez A. Synovial fluid bupivacaine concentrations following single intra-articular injection in normal and osteoarthritic canine stifles. Journal of Veterinary Pharmacology and Therapeutics. 38: 97-100. PMID 25229713 DOI: 10.1111/Jvp.12158  0.678
2014 Martinez SE, Lakowski TM, Davies NM. Enantiospecific analysis of 8-prenylnaringenin in biological fluids by liquid-chromatography-electrospray ionization mass spectrometry: application to preclinical pharmacokinetic investigations. Chirality. 26: 419-26. PMID 24931510 DOI: 10.1002/Chir.22343  0.469
2013 Martinez SE, Sayre CL, Davies NM. Pharmacometrics of 3-methoxypterostilbene: a component of traditional chinese medicinal plants. Evidence-Based Complementary and Alternative Medicine : Ecam. 2013: 261468. PMID 23690839 DOI: 10.1155/2013/261468  0.322
2013 Sayre CL, Takemoto JK, Martinez SE, Davies NM. Chiral analytical method development and application to pre-clinical pharmacokinetics of pinocembrin. Biomedical Chromatography : Bmc. 27: 681-4. PMID 23212747 DOI: 10.1002/Bmc.2853  0.756
2013 Sayre CL, Zhang Y, Martinez SE, Takemoto JK, Davies NM. Stereospecific analytical method development and preliminary in vivo pharmacokinetic characterization of pinostrobin in the rat. Biomedical Chromatography : Bmc. 27: 548-50. PMID 23070926 DOI: 10.1002/Bmc.2834  0.749
2013 Sayre CL, Hopkins M, Takemoto JK, Davies NM. Chiral analytical method development of liquiritigenin with application to a pharmacokinetic study. Biomedical Chromatography : Bmc. 27: 404-6. PMID 22815238 DOI: 10.1002/Bmc.2787  0.757
2013 Martinez SE, Sayre CL, Davies NM. Analysis of 3-methoxypterostilbene in biological fluids by high-performance liquid chromatography: application to pre-clinical pharmacokinetics. Biomedical Chromatography : Bmc. 27: 67-72. PMID 22618645 DOI: 10.1002/Bmc.2749  0.501
2012 Remsberg CM, Zhao Y, Takemoto JK, Bertram RM, Davies NM, Forrest ML. Pharmacokinetic Evaluation of a DSPE-PEG2000 Micellar Formulation of Ridaforolimus in Rat. Pharmaceutics. 5: 81-93. PMID 24300398 DOI: 10.3390/Pharmaceutics5010081  0.803
2012 Cuthbertson D, Andrews PK, Reganold JP, Davies NM, Lange BM. Utility of metabolomics toward assessing the metabolic basis of quality traits in apple fruit with an emphasis on antioxidants. Journal of Agricultural and Food Chemistry. 60: 8552-60. PMID 22881116 DOI: 10.1021/Jf3031088  0.302
2012 Mohamed EA, Zhao Y, Meshali MM, Remsberg CM, Borg TM, Foda AM, Takemoto JK, Sayre CL, Martinez SE, Davies NM, Forrest ML. Vorinostat with sustained exposure and high solubility in poly(ethylene glycol)-b-poly(DL-lactic acid) micelle nanocarriers: characterization and effects on pharmacokinetics in rat serum and urine. Journal of Pharmaceutical Sciences. 101: 3787-98. PMID 22806441 DOI: 10.1002/Jps.23265  0.783
2012 Wright HM, Chen AV, Martinez SE, Davies NM. Pharmacokinetics of oral rufinamide in dogs. Journal of Veterinary Pharmacology and Therapeutics. 35: 529-33. PMID 22132708 DOI: 10.1111/J.1365-2885.2011.01353.X  0.354
2012 Martinez SE, Bowen KA, Remsberg CM, Takemoto JK, Wright HM, Chen-Allen AV, Davies NM. High-performance liquid chromatographic analysis of lacosamide in canine serum using ultraviolet detection: application to pre-clinical pharmacokinetics in dogs. Biomedical Chromatography : Bmc. 26: 606-9. PMID 21898475 DOI: 10.1002/Bmc.1704  0.815
2012 Takemoto JK, Martinez SE, Davies NM. Analysis of Flavonoids through Chromatography Flavonoid Pharmacokinetics: Methods of Analysis, Preclinical and Clinical Pharmacokinetics, Safety, and Toxicology. 71-115. DOI: 10.1002/9781118468524.ch2  0.691
2012 Yáñez JA, Remsberg CM, Takemoto JK, Vega-Villa KR, Andrews PK, Sayre CL, Martinez SE, Davies NM. Polyphenols and Flavonoids: An Overview Flavonoid Pharmacokinetics: Methods of Analysis, Preclinical and Clinical Pharmacokinetics, Safety, and Toxicology. 1-69. DOI: 10.1002/9781118468524.ch1  0.753
2011 Yáñez JA, Remsberg CM, Sayre CL, Forrest ML, Davies NM. Flip-flop pharmacokinetics--delivering a reversal of disposition: challenges and opportunities during drug development. Therapeutic Delivery. 2: 643-72. PMID 21837267 DOI: 10.4155/Tde.11.19  0.698
2011 Diezi TA, Takemoto JK, Davies NM, Kwon GS. Pharmacokinetics and nephrotoxicity of amphotericin B-incorporated poly(ethylene glycol)-block-poly(N-hexyl stearate l-aspartamide) micelles. Journal of Pharmaceutical Sciences. 100: 2064-70. PMID 21491436 DOI: 10.1002/Jps.22445  0.7
2011 Vega-Villa KR, Remsberg CM, Takemoto JK, Ohgami Y, Yáñez JA, Andrews PK, Davies NM. Stereospecific pharmacokinetics of racemic homoeriodictyol, isosakuranetin, and taxifolin in rats and their disposition in fruit. Chirality. 23: 339-48. PMID 21384439 DOI: 10.1002/Chir.20926  0.805
2011 Mostafavi A, Emami J, Varshosaz J, Davies NM, Rezazadeh M. Development of a prolonged-release gastroretentive tablet formulation of ciprofloxacin hydrochloride: pharmacokinetic characterization in healthy human volunteers. International Journal of Pharmaceutics. 409: 128-36. PMID 21371548 DOI: 10.1016/J.Ijpharm.2011.02.035  0.306
2011 Takemoto JK, Davies NM. Method development for β-glucogallin and gallic acid analysis: application to urinary pharmacokinetic studies. Journal of Pharmaceutical and Biomedical Analysis. 54: 812-6. PMID 21130594 DOI: 10.1016/J.Jpba.2010.11.003  0.725
2011 Remsberg CM, Takemoto JK, Bertram RM, Davies NM. High-performance liquid chromatography assay of gnetol in rat serum and application to pre-clinical pharmacokinetic studies. Journal of Pharmaceutical and Biomedical Analysis. 54: 878-81. PMID 21126844 DOI: 10.1016/J.Jpba.2010.10.028  0.835
2010 Remsberg CM, Good RL, Davies NM. Ingredient Consistency of Commercially Available Polyphenol and Tocopherol Nutraceuticals. Pharmaceutics. 2: 50-60. PMID 27721342 DOI: 10.3390/Pharmaceutics2010050  0.672
2010 Serve KM, Darnell JL, Takemoto JK, Davies NM, Black ME. Validation of an isocratic HPLC method to detect 2-fluoro-beta-alanine for the analysis of dihydropyrimidine dehydrogenase activity. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 878: 1889-92. PMID 20570578 DOI: 10.1016/J.Jchromb.2010.05.010  0.724
2010 Mejia-Meza EI, Yáñez JA, Remsberg CM, Takemoto JK, Davies NM, Rasco B, Clary C. Effect of dehydration on raspberries: polyphenol and anthocyanin retention, antioxidant capacity, and antiadipogenic activity. Journal of Food Science. 75: H5-12. PMID 20492178 DOI: 10.1111/J.1750-3841.2009.01383.X  0.787
2010 Davies NM, Takemoto JK, Brocks DR, Yáñez JA. Multiple peaking phenomena in pharmacokinetic disposition. Clinical Pharmacokinetics. 49: 351-77. PMID 20481648 DOI: 10.2165/11319320-000000000-00000  0.702
2010 Cai S, Xie Y, Davies NM, Cohen MS, Forrest ML. Pharmacokinetics and disposition of a localized lymphatic polymeric hyaluronan conjugate of cisplatin in rodents. Journal of Pharmaceutical Sciences. 99: 2664-71. PMID 19960530 DOI: 10.1002/Jps.22016  0.329
2010 Serve KM, Yáñez JA, Remsberg CM, Davies NM, Black ME. Development and validation of a rapid and sensitive HPLC method for the quantification of 5-fluorocytosine and its metabolites. Biomedical Chromatography : Bmc. 24: 556-61. PMID 19795393 DOI: 10.1002/Bmc.1326  0.74
2010 Bertram RM, Takemoto JK, Remsberg CM, Vega-Villa KR, Sablani S, Davies NM. High-performance liquid chromatographic analysis: applications to nutraceutical content and urinary disposition of oxyresveratrol in rats. Biomedical Chromatography : Bmc. 24: 516-21. PMID 19739255 DOI: 10.1002/Bmc.1320  0.817
2010 Remsberg CM, Good RL, Davies NM. Ingredient consistency of commercially available polyphenol and tocopherol nutraceuticals Pharmaceutics. 2: 50-60. DOI: 10.3390/pharmaceutics2010050  0.65
2009 Takemoto JK, Davies NM. A high-performance liquid chromatographic analysis and preliminary pharmacokinetic characterization of 3'-hydroxypterostilbene in rats. Biomedical Chromatography : Bmc. 23: 1086-91. PMID 19385002 DOI: 10.1002/Bmc.1228  0.774
2009 Vega-Villa KR, Remsberg CM, Ohgami Y, Yáñez JA, Takemoto JK, Andrews PK, Davies NM. Stereospecific high-performance liquid chromatography of taxifolin, applications in pharmacokinetics, and determination in tu fu ling (Rhizoma smilacis glabrae) and apple (Malus x domestica). Biomedical Chromatography : Bmc. 23: 638-46. PMID 19267323 DOI: 10.1002/Bmc.1165  0.817
2009 Xiong MP, Yáñez JA, Kwon GS, Davies NM, Forrest ML. A cremophor-free formulation for tanespimycin (17-AAG) using PEO-b-PDLLA micelles: characterization and pharmacokinetics in rats. Journal of Pharmaceutical Sciences. 98: 1577-86. PMID 18752263 DOI: 10.1002/Jps.21509  0.349
2008 Takemoto JK, Reynolds JK, Remsberg CM, Vega-Villa KR, Davies NM. Clinical pharmacokinetic and pharmacodynamic profile of etoricoxib. Clinical Pharmacokinetics. 47: 703-20. PMID 18840026 DOI: 10.2165/00003088-200847110-00002  0.782
2008 Takemoto JK, Remsberg CM, Yáñez JA, Vega-Villa KR, Davies NM. Stereospecific analysis of sakuranetin by high-performance liquid chromatography: pharmacokinetic and botanical applications. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 875: 136-41. PMID 18676186 DOI: 10.1016/J.Jchromb.2008.07.019  0.816
2008 Wang TT, Hudson TS, Wang TC, Remsberg CM, Davies NM, Takahashi Y, Kim YS, Seifried H, Vinyard BT, Perkins SN, Hursting SD. Differential effects of resveratrol on androgen-responsive LNCaP human prostate cancer cells in vitro and in vivo. Carcinogenesis. 29: 2001-10. PMID 18586690 DOI: 10.1093/Carcin/Bgn131  0.661
2008 Vega-Villa KR, Remsberg CM, Podelnyk KL, Davies NM. Stereospecific high-performance liquid chromatographic assay of isosakuranetin in rat urine. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 875: 142-7. PMID 18514595 DOI: 10.1016/J.Jchromb.2008.05.018  0.828
2008 Xiong MP, Yáñez JA, Remsberg CM, Ohgami Y, Kwon GS, Davies NM, Forrest ML. Formulation of a geldanamycin prodrug in mPEG-b-PCL micelles greatly enhances tolerability and pharmacokinetics in rats. Journal of Controlled Release : Official Journal of the Controlled Release Society. 129: 33-40. PMID 18456363 DOI: 10.1016/J.Jconrel.2008.03.015  0.705
2008 Vega-Villa KR, Takemoto JK, Yáñez JA, Remsberg CM, Forrest ML, Davies NM. Clinical toxicities of nanocarrier systems. Advanced Drug Delivery Reviews. 60: 929-38. PMID 18313790 DOI: 10.1016/J.Addr.2007.11.007  0.756
2008 Yáñez JA, Remsberg CM, Miranda ND, Vega-Villa KR, Andrews PK, Davies NM. Pharmacokinetics of selected chiral flavonoids: hesperetin, naringenin and eriodictyol in rats and their content in fruit juices. Biopharmaceutics & Drug Disposition. 29: 63-82. PMID 18058792 DOI: 10.1002/Bdd.588  0.807
2008 Forrest ML, Yáñez JA, Remsberg CM, Ohgami Y, Kwon GS, Davies NM. Paclitaxel prodrugs with sustained release and high solubility in poly(ethylene glycol)-b-poly(epsilon-caprolactone) micelle nanocarriers: pharmacokinetic disposition, tolerability, and cytotoxicity. Pharmaceutical Research. 25: 194-206. PMID 17912488 DOI: 10.1007/S11095-007-9451-9  0.661
2008 Remsberg CM, Yáñez JA, Ohgami Y, Vega-Villa KR, Rimando AM, Davies NM. Pharmacometrics of pterostilbene: preclinical pharmacokinetics and metabolism, anticancer, antiinflammatory, antioxidant and analgesic activity. Phytotherapy Research : Ptr. 22: 169-79. PMID 17726731 DOI: 10.1002/Ptr.2277  0.808
2008 Vega-Villa KR, Yáñez JA, Remsberg CM, Ohgami Y, Davies NM. Stereospecific high-performance liquid chromatographic validation of homoeriodictyol in serum and Yerba Santa (Eriodictyon glutinosum). Journal of Pharmaceutical and Biomedical Analysis. 46: 971-4. PMID 17719196 DOI: 10.1016/J.Jpba.2007.07.020  0.827
2008 Davies NM, Yanez JA, Remsberg CM, Vega-Villa KR, Miranda ND, Navas J, Ohgami Y, McCormick D, Hughes K, Temple C, Martinez SA. Pharmacological Evaluation of Glyco-Flex® III and its Constituents on Canine Chondrocytes Journal of Medical Sciences(Faisalabad). 8: 1-14. DOI: 10.3923/Jms.2008.1.14  0.772
2008 Mejia-Meza EI, Yanez JA, Davies NM, Rasco B, Younce F, Remsberg CM, Clary C. Improving Nutritional Value of Dried Blueberries (Vaccinium corymbosum L.) Combining Microwave-Vacuum, Hot-Air Drying and Freeze Drying Technologies International Journal of Food Engineering. 4. DOI: 10.2202/1556-3758.1364  0.683
2008 Escudero MR, Fernando Ramos Escudero D, Remsberg CM, Takemoto JK, Davies NM, Yáñez JA. Identification of Polyphenols and Anti-Oxidant Capacity of Piper aduncum L The Open Bioactive Compounds Journal. 1: 18-21. DOI: 10.2174/1874847300801010018  0.78
2007 Hesse C, Razmovski-Naumovski V, Duke CC, Davies NM, Roufogalis BD. Phytopreventative effects of Gynostemma pentaphyllum against acute Indomethacin-induced gastrointestinal and renal toxicity in rats. Phytotherapy Research : Ptr. 21: 523-30. PMID 17380554 DOI: 10.1002/Ptr.2086  0.325
2007 Yáñez JA, Andrews PK, Davies NM. Methods of analysis and separation of chiral flavonoids. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 848: 159-81. PMID 17113835 DOI: 10.1016/J.Jchromb.2006.10.052  0.343
2007 Remsberg CM, Yáñez JA, Roupe KA, Davies NM. High-performance liquid chromatographic analysis of pterostilbene in biological fluids using fluorescence detection. Journal of Pharmaceutical and Biomedical Analysis. 43: 250-4. PMID 16884886 DOI: 10.1016/J.Jpba.2006.06.035  0.824
2007 Yáñez JA, Miranda ND, Remsberg CM, Ohgami Y, Davies NM. Stereospecific high-performance liquid chromatographic analysis of eriodictyol in urine. Journal of Pharmaceutical and Biomedical Analysis. 43: 255-62. PMID 16876977 DOI: 10.1016/J.Jpba.2006.06.027  0.771
2006 Roupe KA, Remsberg CM, Yáñez JA, Davies NM. Pharmacometrics of stilbenes: seguing towards the clinic. Current Clinical Pharmacology. 1: 81-101. PMID 18666380 DOI: 10.2174/157488406775268246  0.765
2006 Davies NM, Good RL, Roupe KA, Yanez JA. Correction. Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society For Pharmaceutical Sciences, SociéTé Canadienne Des Sciences Pharmaceutiques. 9: following 433. PMID 17211951  0.709
2006 Davies NM, Reynolds JK, Undeberg MR, Gates BJ, Ohgami Y, Vega-Villa KR. Minimizing risks of NSAIDs: cardiovascular, gastrointestinal and renal. Expert Review of Neurotherapeutics. 6: 1643-55. PMID 17144779 DOI: 10.1586/14737175.6.11.1643  0.746
2006 Roupe KA, Yáñez JA, Teng XW, Davies NM. Pharmacokinetics of selected stilbenes: rhapontigenin, piceatannol and pinosylvin in rats. The Journal of Pharmacy and Pharmacology. 58: 1443-50. PMID 17132206 DOI: 10.1211/Jpp.58.11.0004  0.788
2005 Roupe KA, Helms GL, Halls SC, Yáñez JA, Davies NM. Preparative enzymatic synthesis and HPLC analysis of rhapontigenin: applications to metabolism, pharmacokinetics and anti-cancer studies. Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society For Pharmaceutical Sciences, SociéTé Canadienne Des Sciences Pharmaceutiques. 8: 374-86. PMID 16401387  0.781
2005 Torres CA, Davies NM, Yañez JA, Andrews PK. Disposition of selected flavonoids in fruit tissues of various tomato (lycopersicon esculentum mill.) Genotypes. Journal of Agricultural and Food Chemistry. 53: 9536-43. PMID 16302774 DOI: 10.1021/Jf051176T  0.335
2005 Gates BJ, Nguyen TT, Setter SM, Davies NM. Meloxicam: a reappraisal of pharmacokinetics, efficacy and safety. Expert Opinion On Pharmacotherapy. 6: 2117-40. PMID 16197363 DOI: 10.1517/14656566.6.12.2117  0.336
2005 Yáñez JA, Davies NM. Stereospecific high-performance liquid chromatographic analysis of naringenin in urine. Journal of Pharmaceutical and Biomedical Analysis. 39: 164-9. PMID 16085136 DOI: 10.1016/J.Jpba.2005.02.025  0.502
2005 Good RL, Roupe KA, Fukuda C, Clifton GD, Fariss MW, Davies NM. Direct high-performance liquid chromatographic analysis of D-tocopheryl acid succinate and derivatives. Journal of Pharmaceutical and Biomedical Analysis. 39: 33-8. PMID 16085132 DOI: 10.1016/J.Jpba.2005.02.029  0.802
2005 Roupe K, Halls S, Davies NM. Determination and assay validation of pinosylvin in rat serum: application to drug metabolism and pharmacokinetics. Journal of Pharmaceutical and Biomedical Analysis. 38: 148-54. PMID 15907633 DOI: 10.1016/J.Jpba.2004.12.015  0.824
2005 Teng XW, Davies NM, Fukuda C, Good RL, Fariss MW. Pharmacokinetics and tissue distribution of d-alpha-tocopheryl succinate formulations following intravenous administration in the rat. Biopharmaceutics & Drug Disposition. 26: 195-203. PMID 15900617 DOI: 10.1002/Bdd.451  0.332
2005 Yáñez JA, Teng XW, Roupe KA, Davies NM. Stereospecific high-performance liquid chromatographic analysis of hesperetin in biological matrices. Journal of Pharmaceutical and Biomedical Analysis. 37: 591-5. PMID 15740921 DOI: 10.1016/J.Jpba.2004.10.028  0.827
2004 Roupe K, Teng XW, Fu X, Meadows GG, Davies NM. Determination of piceatannol in rat serum and liver microsomes: pharmacokinetics and phase I and II biotransformation. Biomedical Chromatography : Bmc. 18: 486-91. PMID 15386525 DOI: 10.1002/Bmc.342  0.816
2004 Davies NM, Good RL, Roupe KA, Yáñez JA. Cyclooxygenase-3: axiom, dogma, anomaly, enigma or splice error?--Not as easy as 1, 2, 3. Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society For Pharmaceutical Sciences, SociéTé Canadienne Des Sciences Pharmaceutiques. 7: 217-26. PMID 15367379  0.74
2004 Teng XW, Davies NM. High-performance liquid chromatographic analysis of a selective cyclooxygenase-1 inhibitor SC-560 in rat serum: application to pharmacokinetic studies. Journal of Pharmaceutical and Biomedical Analysis. 35: 1143-7. PMID 15336360 DOI: 10.1016/J.Jpba.2004.03.013  0.512
2003 Yáñez JA, Teng XW, Roupe KA, Fariss MW, Davies NM. Chemotherapy induced gastrointestinal toxicity in rats: involvement of mitochondrial DNA, gastrointestinal permeability and cyclooxygenase -2. Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society For Pharmaceutical Sciences, SociéTé Canadienne Des Sciences Pharmaceutiques. 6: 308-14. PMID 14738710  0.756
2003 Teng XW, Wang SW, Davies NM. Stereospecific high-performance liquid chromatographic analysis of ibuprofen in rat serum. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 796: 225-31. PMID 14581063 DOI: 10.1016/J.Jchromb.2003.07.010  0.493
2003 Teng XW, Wang SW, Davies NM. Stereospecific high-performance liquid chromatographic analysis of flurbiprofen: application to pharmacokinetic studies. Journal of Pharmaceutical and Biomedical Analysis. 33: 95-100. PMID 12946535 DOI: 10.1016/S0731-7085(03)00340-6  0.516
2003 Teng XW, Cutler DJ, Davies NM. Kinetics of metabolism and degradation of mometasone furoate in rat biological fluids and tissues. The Journal of Pharmacy and Pharmacology. 55: 617-30. PMID 12831504 DOI: 10.1211/002235703765344522  0.322
2003 Davies NM, Teng XW, Skjodt NM. Pharmacokinetics of rofecoxib: a specific cyclo-oxygenase-2 inhibitor. Clinical Pharmacokinetics. 42: 545-56. PMID 12793839 DOI: 10.2165/00003088-200342060-00004  0.325
2003 Davies NM, Feddah MR. A novel method for assessing dissolution of aerosol inhaler products. International Journal of Pharmaceutics. 255: 175-87. PMID 12672613 DOI: 10.1016/S0378-5173(03)00091-7  0.308
2002 Davies NM, Gudde TW, de Leeuw MA. Celecoxib: a new option in the treatment of arthropathies and familial adenomatous polyposis. Expert Opinion On Pharmacotherapy. 2: 139-52. PMID 11336575 DOI: 10.1517/14656566.2.1.139  0.316
2001 Teng XW, Foe K, Brown KF, Cutler DJ, Davies NM. High-performance liquid chromatographic analysis of mometasone furoate and its degradation products: application to in vitro degradation studies. Journal of Pharmaceutical and Biomedical Analysis. 26: 313-9. PMID 11470208 DOI: 10.1016/S0731-7085(01)00408-3  0.463
2000 Davies NM, Skjodt NM. Choosing the right nonsteroidal anti-inflammatory drug for the right patient: a pharmacokinetic approach. Clinical Pharmacokinetics. 38: 377-92. PMID 10843458 DOI: 10.2165/00003088-200038050-00001  0.365
2000 Davies NM, McLachlan AJ, Day RO, Williams KM. Clinical pharmacokinetics and pharmacodynamics of celecoxib: a selective cyclo-oxygenase-2 inhibitor. Clinical Pharmacokinetics. 38: 225-42. PMID 10749518 DOI: 10.2165/00003088-200038030-00003  0.382
1999 Skjodt NM, Davies NM. Clinical pharmacokinetics and pharmacodynamics of bromfenac. Clinical Pharmacokinetics. 36: 399-408. PMID 10427465 DOI: 10.2165/00003088-199936060-00002  0.365
1999 Davies NM, Skjodt NM. Clinical pharmacokinetics of meloxicam. A cyclo-oxygenase-2 preferential nonsteroidal anti-inflammatory drug. Clinical Pharmacokinetics. 36: 115-26. PMID 10092958 DOI: 10.2165/00003088-199936020-00003  0.353
1999 Jamali F, Lovlin R, Corrigan BW, Davies NM, Aberg G. Stereospecific pharmacokinetics and toxicodynamics of ketorolac after oral administration of the racemate and optically pure enantiomers to the rat. Chirality. 11: 201-5. PMID 10079499 DOI: 10.1002/(Sici)1520-636X(1999)11:3<201::Aid-Chir5>3.0.Co;2-Z  0.348
1999 Davies NM. Clinical pharmacokinetics of oxaprozin. Clinical Pharmacokinetics. 35: 425-36. PMID 9884815 DOI: 10.2165/00003088-199835060-00002  0.37
1998 Skjodt NM, Davies NM. Clinical pharmacokinetics of lornoxicam. A short half-life oxicam. Clinical Pharmacokinetics. 34: 421-8. PMID 9646006 DOI: 10.2165/00003088-199834060-00001  0.339
1998 Davies NM. Clinical pharmacokinetics of ibuprofen. The first 30 years. Clinical Pharmacokinetics. 34: 101-54. PMID 9515184 DOI: 10.2165/00003088-199834020-00002  0.383
1998 Davies NM. Clinical pharmacokinetics of nabumetone. The dawn of selective cyclo-oxygenase-2 inhibition? Clinical Pharmacokinetics. 33: 404-16. PMID 9435990 DOI: 10.2165/00003088-199733060-00001  0.355
1997 Wright MR, Davies NM, Jamali F. Toxicokinetics of indomethacin-induced intestinal permeability in the rat. Pharmacological Research. 35: 499-504. PMID 9356198 DOI: 10.1006/Phrs.1997.0194  0.35
1997 Davies NM, Andersen KE. Clinical pharmacokinetics of diclofenac. Therapeutic insights and pitfalls Clinical Pharmacokinetics. 33: 184-213. PMID 9314611 DOI: 10.2165/00003088-199733030-00003  0.367
1997 Davies NM, Jamali F. Pharmacological protection of NSAID-induced intestinal permeability in the rat: effect of tempo and metronidazole as potential free radical scavengers. Human & Experimental Toxicology. 16: 345-9. PMID 9257157 DOI: 10.1177/096032719701600701  0.332
1997 Davies NM, Watson MS. Clinical pharmacokinetics of sulindac: A dynamic old drug Clinical Pharmacokinetics. 32: 437-459. PMID 9195115 DOI: 10.2165/00003088-199732060-00002  0.376
1997 Davies NM. Methods of analysis of chiral non-steroidal anti-inflammatory drugs. Journal of Chromatography. B, Biomedical Sciences and Applications. 691: 229-61. PMID 9174260 DOI: 10.1016/S0378-4347(96)00442-2  0.353
1997 Davies NM. Clinical pharmacokinetics of tiaprofenic acid and its enantiomers. Clinical Pharmacokinetics. 31: 331-47. PMID 9118583 DOI: 10.2165/00003088-199631050-00002  0.349
1997 Davies NM, Anderson KE. Clinical pharmacokinetics of naproxen. Clinical Pharmacokinetics. 32: 268-93. PMID 9113437 DOI: 10.2165/00003088-199732040-00002  0.367
1997 Davies NM, Røseth AG, Appleyard CB, McKnight W, Del Soldato P, Calignano A, Cirino G, Wallace JL. NO-naproxen vs. naproxen: ulcerogenic, analgesic and anti-inflammatory effects. Alimentary Pharmacology & Therapeutics. 11: 69-79. PMID 9042976 DOI: 10.1046/J.1365-2036.1997.115286000.X  0.309
1997 Reuter BK, Davies NM, Wallace JL. Nonsteroidal anti-inflammatory drug enteropathy in rats: role of permeability, bacteria, and enterohepatic circulation. Gastroenterology. 112: 109-17. PMID 8978349 DOI: 10.1016/S0016-5085(97)70225-7  0.341
1997 Davies NM, Wright MR, Russell AS, Jamali F. Effect of the enantiomers of flurbiprofen, ibuprofen, and ketoprofen on intestinal permeability. Journal of Pharmaceutical Sciences. 85: 1170-3. PMID 8923320 DOI: 10.1021/Js960276Y  0.328
1996 Davies NM, Wallace JL. Selective inhibitors of cyclooxygenase-2. Potential in elderly patients. Drugs & Aging. 9: 406-17. PMID 8972241 DOI: 10.2165/00002512-199609060-00004  0.304
1996 Davies NM, Corrigan BW, Jamali F. Sucrose urinary excretion in the rat measured using a simple assay: a model of gastroduodenal permeability. Pharmaceutical Research. 12: 1733-6. PMID 8592678 DOI: 10.1023/A:1016221923679  0.328
1995 Davies NM, Wright MR, Jamali F. Antiinflammatory drug-induced small intestinal permeability: the rat is a suitable model. Pharmaceutical Research. 11: 1652-6. PMID 7870685 DOI: 10.1023/A:1018978308752  0.359
1995 Davies NM. Clinical pharmacokinetics of flurbiprofen and its enantiomers. Clinical Pharmacokinetics. 28: 100-14. PMID 7736686 DOI: 10.2165/00003088-199528020-00002  0.393
Show low-probability matches.